Windlas Biotech Releases Audio Recording for Q2 FY27 Earnings Call
Windlas Biotech Ltd 路 Intimation 路 07 Nov 2026, 2:01 am
Windlas Biotech Releases Audio Recording for Q2 FY27 Earnings Call Windlas Biotech Limited informed stock exchanges on 6th Nov'26 that the audio recording of its investor and analyst conference call鈥攃overing the unaudited standalone financial results for the quarter and half-year ended 30th Sep'26鈥攊s now available on the company's website. The written transcript of the earnings call will be submitted to the exchanges and published online in due course, pursuant to Regulation 30 of the SEBI LODR Regulations.
Original exchange filing (PDF)
More announcements from Windlas Biotech Ltd
- Q2 & H1 FY27 Earnings Conference Call Transcript 路 13 Nov 2026
- press release titled 'Windlas Biotech Limited Reports its H1 & Q2 FY27 Financial Results" 路 05 Nov 2026
- Mr. Ashok Kumar Windlass, has been appointed, as Founder President (Senior Management Personnel) of the Company, effective from November 6, 2026. 路 05 Nov 2026
- resignation of Mr. Ashok Kumar Windlass (DIN: 00011451) from the position of Whole-time Director and Director of the Company with effect from November 5, 2026 at 10.00 A.M. 路 05 Nov 2026
- Investor Presentation - Q2 & H1FY27, 路 05 Nov 2026
- Windlas Biotech Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 05 Nov 2026
- Approval inter alia unaudited financial results for the quarter and half year ended September 30, 2026 路 05 Nov 2026
- The Board approved inter alia financial results for the quarter and half year ended September 30 2026. 路 05 Nov 2026
